Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Invicta Diagnostic Ltd
Invicta Diagnostic Ltd

Invicta Diagnostic Ltd (INVICTA) Share Price

  • Sector: Healthcare (Small Cap)
  • Volume: 1,48,800
Dec 19, 2025
  • NSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹81.85
₹-1.15 (-1.39%)
79.00Low
Today’s Performance
83.50High
79.00Low
52 Week’s Performance
105.00High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-1.39%
  • 1 Week-7.78%
  • 1 Month-14.17%
  • 3 Months-%
  • 6 Months-%
  • 1 Year-%
  • 3 Years-%
  • 5 Years-%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta-2.64
  • 52-Week Low (₹)81.10
  • 52-Week High (₹)105.00
  • Price-to-Book (X)*2.05
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*22.25
  • Earnings Per Share (₹)3.73
  • Market Cap (₹ Cr.)*104.35
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Weak Rupee, Strong Strategy? ASK Investment's Sandip Bansal Explains2:01Weak Rupee, Strong Strategy? ASK Investment's Sandip Bansal Explains
IT, Pharma Shine As Inflation Data Boosts Risk Appetite | Market Guru Sadip Bansal20:58IT, Pharma Shine As Inflation Data Boosts Risk Appetite | Market Guru Sadip Bansal
BFSI, IT & Cyclicals: Where Smart Money Is Moving? Sandip Bansal Answers1:50BFSI, IT & Cyclicals: Where Smart Money Is Moving? Sandip Bansal Answers
Lok Sabha In Chaos As Contentious G Ram G Bill Passed Amid Protests, Slogans And Opposition Fury3:48Lok Sabha In Chaos As Contentious G Ram G Bill Passed Amid Protests, Slogans And Opposition Fury
Parliament Clears SHANTI Bill, Opening India’s Nuclear Sector To Private Players Amid Opposition Concerns3:02Parliament Clears SHANTI Bill, Opening India’s Nuclear Sector To Private Players Amid Opposition
NIFTY 2026: Financials, IT & Insurance to Drive Next Phase of Returns3:30NIFTY 2026: Financials, IT & Insurance To Drive Next Phase Of Returns
Delhi Pollution Crackdown: Even MLA Vehicles Stopped, Challaned At Borders2:02Delhi Pollution Crackdown: Even MLA Vehicles Stopped, Challaned At Borders
RP–Sanjiv Goenka Group Announces ₹15,800 Crore Investment Plan Across Energy, Education And Healthcare In Bengal4:27RP–Sanjiv Goenka Group Announces ₹15,800 Cr Investment Plan Across Energy, Education & Healthcare
Beyond Goals And Glory: Lionel Messi’s Quiet, Powerful Visit To India’s Vantara3:00Beyond Goals And Glory: Lionel Messi’s Quiet, Powerful Visit To India’s Vantara
From Caution To Conviction: Why IT Is Back On Fund Managers’ Radar1:18From Caution To Conviction: Why IT Is Back On Fund Managers’ Radar
View more

bt_logoFAQ's

What was Invicta Diagnostic Ltd share price previously?
Invicta Diagnostic Ltd share price was down by -1.39% from the previous closing price of ₹83.00.
Who are peers of Invicta Diagnostic Ltd?
The peers of Invicta Diagnostic Ltd are Max Healthcare Institute Ltd, Apollo Hospitals Enterprise Ltd, Fortis Healthcare Ltd, Narayana Hrudayalaya Ltd, Global Health Ltd, Aster DM Healthcare Ltd, Syngene International Ltd, Krishna Institute of Medical Sciences Ltd, Dr Lal Pathlabs Ltd, Poly Medicure Ltd.
Who is/are the promoter/promoters of Invicta Diagnostic Ltd?
The promotor/promotors of Invicta Diagnostic Ltd are Ketan Jayantilal Jain, Sanket Vinod Jain, Aayush Kamleshbhai Shah, Shilpa Ajay Bhatia, Soniya Nilesh Mahajan.
What has been 52-week high of Invicta Diagnostic Ltd stocks?
The highest price of Invicta Diagnostic Ltd stock is ₹105.00 in the last 52-week.
What is the share price of Invicta Diagnostic Ltd (INVICTA) today on NSE?
As on Dec 19, 2025 Invicta Diagnostic Ltd (INVICTA)’s share price on NSE is Rs 81.85
What is the market cap of Invicta Diagnostic Ltd (INVICTA)?
The current market capitalisation of Invicta Diagnostic Ltd (INVICTA) is 104.35 crores
What is Invicta Diagnostic Ltd Share symbol?
The symbol of Invicta Diagnostic Ltd is INVICTA.
What is the PE ratio of Invicta Diagnostic Ltd (INVICTA)?
The current PE ratio of Invicta Diagnostic Ltd (INVICTA) is 22.25.
What is the PB ratio of Invicta Diagnostic Ltd (INVICTA)?
The current PB ratio of Invicta Diagnostic Ltd (INVICTA) is 2.05.
Today’s High & Low share prices of Invicta Diagnostic Ltd (INVICTA) on NSE?
Today, the share price of Invicta Diagnostic Ltd (INVICTA) on NSE touched a high of Rs 83.5 and a low of Rs 79
What price did Invicta Diagnostic Ltd (INVICTA) shares open on the NSE today?
On NSE, the share price of Invicta Diagnostic Ltd (INVICTA) opened at Rs 83
What is the 52-week high of Invicta Diagnostic Ltd (INVICTA)?
The 52-week high price of Invicta Diagnostic Ltd (INVICTA) is Rs 105.00
What is the 52-week low of Invicta Diagnostic Ltd (INVICTA)?
The 52-week low price of Invicta Diagnostic Ltd (INVICTA) is Rs 79.00

bt_logoAbout Invicta Diagnos.

Invicta Diagnostic Ltd, incorporated in the year 2023, has its registered office in 1 GF Plot 217 Ambavat Bhavan, N.M.Joshi Marg Delisle Road, Mumbai, Maharashtra, 400013, 022 4971 0036. The main industry in which Invicta Diagnostic Ltd operates is Healthcare.

Auditor/Auditors for Invicta Diagnostic Ltd is/are Kanak Rathod & Co. In the main management, Sanket Vinod Jain is chairman and Soniya Nilesh Mahajan is the company secretary for Invicta Diagnostic Ltd.

  • KJJ
    Ketan Jayantilal JainNon Executive Director
  • SVJ
    Sanket Vinod JainChairman (Non-Executive)
  • AKS
    Aayush Kamleshbhai ShahIndependent Director
  • SAB
    Shilpa Ajay BhatiaIndependent Director
  • SNM
    Soniya Nilesh MahajanCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.